1. AYA, T., MIZUNO, F., and OSATO, T., Immunologic cytotoxicity against autologous human lymphocytes transformed or infected by Epstein-Barr virus: role of antibody-dependent cellular cytotoxicity in healthy individuals. J. nat. Cancer Inst., 65, 265–271 (1980).
2. BAER, R., BANKIER, A. T., BIGGIN, M. D., DEININGER, P. L., FARRELL, P. J., GIBSON, T. J., HATFULL, G., HUDSON, G. S., SATCHWELL, S. D., SEGUIN, C., TUFFNELL, P. S., and BARRELL, B. G., DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature, 310, 207–211 (1984).
3. EDSON, C. M.,and THORLEY-LAWSON, D. A. Epstein-Barr virus membrane antigens: characterization, distribution, and strain differences.J. Virol.,39,172–184 (1981).
4. BLAZAR, B. A., FITGERALD, J., SUTTON, L., and STROME, M., Increased sensitivity to natural killing in Raji cells is due to effector recognition of molecules appearing on target cell membranes following EBV cycle induction. Clin. exp. Immunol.,54, 31–38 (1983).
5. BLAZAR, B. A., STROME, M., and SCHOOLEY, R.,Interferon and natural killing of human lymphoma cell lines after induction of the Epstein-Barr viral cycle by superinfection.J. Immunol.,132, 816–820 (1984).